☆ 4.5 Article

COVID-19-associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates

MYCOSES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes et al.

Summary: Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a common complication among critically ill COVID-19 patients in ICU. It is more prevalent in older patients, those receiving invasive ventilation, and those receiving tocilizumab treatment. CAPA is an independent predictor of ICU mortality.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Article Dermatology

COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series

Eelco F. J. Meijer et al.

Summary: CAPA has emerged as an invasive fungal disease affecting previously immunocompetent, mechanically ventilated ICU patients with high mortality. This study found a significant decrease in the number of COVID-19 patients needing mechanical ventilation in the ICU during the second wave, but a slightly higher percentage were diagnosed with CAPA. The use of dexamethasone did not show significant impact on CAPA incidence or mortality rates.

MYCOSES (2021)

添加到收藏夹

Article Microbiology

Evaluation of Three Commercial PCR Assays for the Detection of Azole-Resistant Aspergillus fumigatus from Respiratory Samples of Immunocompromised Patients

Ulrike Scharmann et al.

Summary: This study compared three commercially available PCR assays for detecting Aspergillus DNA from respiratory specimens of immunocompromised patients and the presence of cyp51A gene mutations. The tested PCR assays were capable of reliably detecting A. fumigatus DNA and differentiating common cyp51A gene mutations. However, the AsperGenius(R) assay had a low risk of false positive results.

JOURNAL OF FUNGI (2021)

添加到收藏夹

Review Microbiology

Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance

Caroline Burks et al.

Summary: Aspergillus fumigatus, an opportunistic human pathogen, causes aspergillosis, with an increasing number of azole-resistant strains being reported globally. Azole-resistant A. fumigatus has been found on every continent except Antarctica, with Europe having the highest number of reports.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Microbiology

Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus

Jacob L. Steenwyk et al.

Summary: The study analyzed the genomes and phenotypic profiles of four COVID-19-associated pulmonary aspergillosis (CAPA) isolates of Aspergillus fumigatus from patients in Germany, finding that these isolates were generally similar to other reference strains, but with some variations in virulence due to gene mutations. These findings contribute to expanding our understanding of COVID-19-associated pulmonary aspergillosis.

MICROBIOLOGY SPECTRUM (2021)

添加到收藏夹

Article Immunology

Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1

Nico A. F. Janssen et al.

Summary: An observational study found an incidence of 10%-15% of coronavirus-disease associated pulmonary aspergillosis in intensive care units, with several factors independently associated with the disease in one cohort and mortality rates ranging from 43%-52%.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

COVID-19-Associated Pulmonary Aspergillosis, March-August 2020

Jon Salmanton-Garcia et al.

Summary: This study found that most patients with coronavirus disease-associated pulmonary aspergillosis (CAPA) are diagnosed shortly after admission, with the majority being treated in the ICU. Azole-resistant strains of Aspergillus fumigatus were common in patients, and voriconazole was the main treatment choice. The overall mortality rate was approximately 52.2%, with about one third of deaths attributed to CAPA.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Critical Care Medicine

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Xiaobo Yang et al.

Lancet Respiratory Medicine (2020)

添加到收藏夹

Article Dermatology

COVID-19 associated pulmonary aspergillosis

Philipp Koehler et al.

MYCOSES (2020)

添加到收藏夹

Letter Infectious Diseases

Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients

Frederic Lamoth et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

添加到收藏夹

Article Dermatology

COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan

Nosheen Nasir et al.

MYCOSES (2020)

添加到收藏夹

Review Infectious Diseases

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Philipp Koehler et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Infectious Diseases

FunResDB-A web resource for genotypic susceptibility testing of Aspergillus fumigatus

Michael Weber et al.

MEDICAL MYCOLOGY (2018)

添加到收藏夹

Article Microbiology

Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland

Arnaud Riat et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

添加到收藏夹

Article Microbiology

Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms

Rocio Garcia-Rubio et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

添加到收藏夹

Article Infectious Diseases

Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany

R. Seufert et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

添加到收藏夹

Letter Critical Care Medicine

Influenza-associated Aspergillosis in Critically III Patients

Frank L. van de Veerdonk et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

添加到收藏夹

Article Dermatology

Diagnosis and management of aspergillosis in the Netherlands: a national survey

Pieter P. A. Lestrade et al.

MYCOSES (2016)

添加到收藏夹

Article Infectious Diseases

High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients

J. Fuhren et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)

添加到收藏夹

Article Infectious Diseases

Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: Is it de novo or environmentally acquired?

Cheshta Sharma et al.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2015)

添加到收藏夹

Article Critical Care Medicine

A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients

Stijn I. Blot et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

添加到收藏夹

Review Cell Biology

Hidden Killers: Human Fungal Infections

Gordon D. Brown et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

添加到收藏夹

Article Microbiology

Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates

HA de Valk et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2005)

添加到收藏夹

Article Infectious Diseases

Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma

J Chen et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)

添加到收藏夹

Review Immunology

Aspergillosis case - Fatality rate: Systematic review of the literature

SJ Lin et al.

CLINICAL INFECTIOUS DISEASES (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.